| 1 |
Long-term use of metformin and Alzheimer’s disease: beneficial or detrimental effects |
|
|
| Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Hebatallah M. Saad, Gaber El-Saber Batiha |
|
| Inflammopharmacology. 2023; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
THE ROLE OF NEUTROPHIL EXTRACELLULAR TRAPS (NETS)
IN THE IMMUNOPATHOGENESIS OF SEVERE COVID-19: POTENTIAL IMMUNOTHERAPEUTIC STRATEGIES REGULATING NET FORMATION AND ACTIVITY |
|
|
| Irina Vadimovna Nesterova, Margarita Galimovna Atazhakhova, Yuri Valerievi?h Teterin, Valeriya Aleksandrovna Matushkina, Galina Anatolievna Chudilova, Marina Nikolaevna Mitropanova |
|
| Russian Journal of Infection and Immunity. 2023; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Impact of Sitagliptin on Non-diabetic Covid-19 Patients |
|
|
| Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Naeem Qusty, Athanasios Alexiou, Gaber El-Saber Batiha |
|
| Current Molecular Pharmacology. 2022; 15(4): 683 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship |
|
|
| Gaber El-Saber Batiha, Hayder M. Al-kuraishy, Thabat J. Al-Maiahy, Ali K. Al-Buhadily, Hebatallah M. Saad, Ali I. Al-Gareeb, Jesus Simal-Gandara |
|
| Diabetology & Metabolic Syndrome. 2022; 14(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Potential Therapeutic Benefits of Metformin Alone and in Combination with Sitagliptin in the Management of Type 2 Diabetes Patients with COVID-19 |
|
|
| Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Sarah M. Albogami, Sabatier Jean-Marc, Eman Hassan Nadwa, Amin A. Hafiz, Walaa A. Negm, Marwa Kamal, Mohammed Al-Jouboury, Engy Elekhnawy, Gaber El-Saber Batiha, Michel De Waard |
|
| Pharmaceuticals. 2022; 15(11): 1361 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Novel Hit of DPP-4Is as Promising Antihyperglycemic Agents with Dual Antioxidant /Anti-Inflammatory Effects for Type 2 Diabetic Patients withCOVID-19 |
|
|
| Shahenda Mahgoub, Samar S. Fatahala, Amira I. Sayed, Hanaa B. Atya, Mohamed F. El-Shehry, Hala Afifi, Samir M. Awad, Rania H. Abd El-Hameed, Heba Taha |
|
| Bioorganic Chemistry. 2022; : 106092 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality |
|
|
| Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Hany Akeel Al-hussaniy, Nasser A. Hadi Al-Harcan, Athanasios Alexiou, Gaber El-Saber Batiha |
|
| International Immunopharmacology. 2022; : 108516 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Apelin controls emotional behavior in age- and metabolic state-dependent manner |
|
|
| S Bullich, P de Souto Barreto, A Dortignac, L He, C Dray, P Valet, BP Guiard |
|
| Psychoneuroendocrinology. 2022; : 105711 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
The Prospective Effect of Allopurinol on the Oxidative Stress Index and Endothelial Dysfunction in Covid-19 |
|
|
| Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Marwa S. Al-Niemi, Reem M. Aljowaie, Saeedah Musaed Almutairi, Athanasios Alexiou, Gaber El-Saber Batiha |
|
| Inflammation. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons |
|
|
| Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Luay Alkazmi, Ola A. Habotta, Gaber El-Saber Batiha |
|
| Inflammopharmacology. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Is sitagliptin effective for SARS-CoV-2 infection: false or true prophecy? |
|
|
| Basil Mohammed Alomair, Hayder M. Al-kuraishy, Ali K. Al-Buhadily, Ali I. Al-Gareeb, Michel De Waard, Engy Elekhnawy, Gaber El-Saber Batiha |
|
| Inflammopharmacology. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Common NLRP3 inflammasome inhibitors and Covid-19: Divide and Conquer |
|
|
| Gaber E. Batiha, Ali I. Al-Gareeb, Damilare Rotimi, Oluyomi Stephen Adeyemi, Hayder M. Al-kuraishy |
|
| Scientific African. 2022; : e01407 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Metformin and growth differentiation factor 15 (
GDF15
) in type 2 diabetes mellitus: A hidden treasure
|
|
|
| Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Athanasios Alexiou, Marios Papadakis, Eman Hassan Nadwa, Sarah M. Albogami, Mohammed Alorabi, Hebatallah M. Saad, Gaber El-Saber Batiha |
|
| Journal of Diabetes. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications |
|
|
| Bao Sun,Zhiying Luo,Jiecan Zhou |
|
| Cardiovascular Diabetology. 2021; 20(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
Common NLRP3 inflammasome inhibitors and Covid-19: Divide and Conquer |
|
|
| Gaber El-Saber Batiha, Dr. Ali I. Al-Gareeb, Safaa Qusti, Eida M. Alshammari, Damilare Rotimi, Oluyomi Stephen Adeyemi, Hayder M. Al-kuraishy |
|
| Scientific African. 2021; : e01084 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus |
|
|
| Hayder M. Al-kuraishy,Ali I. Al-Gareeb,M. Alblihed,Susana G. Guerreiro,Natália Cruz-Martins,Gaber El-Saber Batiha |
|
| Frontiers in Cardiovascular Medicine. 2021; 8 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin |
|
|
| Hayder M. Al-kuraishy,Ali I. Al-Gareeb,M. Alblihed,Natália Cruz-Martins,Gaber El-Saber Batiha |
|
| Frontiers in Medicine. 2021; 8 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review |
|
|
| Amany Magdy Beshbishy,Victor B. Oti,Diaa E. Hussein,Ibrahim F. Rehan,Oluyomi S. Adeyemi,Nallely Rivero-Perez,Adrian Zaragoza-Bastida,Muhammad Ajmal Shah,Khaled Abouelezz,Helal F. Hetta,Natália Cruz-Martins,Gaber El-Saber Batiha |
|
| Frontiers in Public Health. 2021; 9 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
